Kyoto, Japan

Sawako Hyo

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sawako Hyo. Retrieved from https://idiyas.com/inventor/sawako-hyo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sawako Hyo: Innovator in Eosinophilic Inflammatory Disease Diagnosis

Introduction

Sawako Hyo is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of medical diagnostics, particularly in eosinophilic inflammatory diseases. Her innovative work has the potential to improve patient outcomes and enhance the understanding of these complex conditions.

Latest Patents

Sawako Hyo holds a patent for a method that aids in the diagnosis of the severity and prediction of recurrence in eosinophilic inflammatory diseases. This method is particularly applicable to conditions such as nasal polyps. The patent represents a significant advancement in the ability to assess and manage these diseases effectively. She has 1 patent to her name.

Career Highlights

Hyo is currently associated with Taiho Pharmaceutical Company Limited, where she continues to work on innovative solutions in the medical field. Her dedication to research and development has positioned her as a key figure in her area of expertise.

Collaborations

Throughout her career, Sawako Hyo has collaborated with notable colleagues, including Kosuke Aritake and Hiroshi Takenaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Sawako Hyo's contributions to the diagnosis and management of eosinophilic inflammatory diseases highlight her role as an influential inventor in the medical field. Her work not only advances scientific knowledge but also has the potential to significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…